HamodaHMukherjeeAMorrisE, et al.Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause. Post Reprod Health20220(0) 1–2.
BrayFFerlayJSoerjomataramI, et al.Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cance rs in 185 countries. CA Cancer J Clin2018; 68(6): 394–424.
World Cancer Research Fund/American Institute for Cancer Research. Continuous update project expert report2018.
6.
SurianoK.A.McHaleMMcLarenCE, et al.Estrogen replacement therapy in endometrial cancer patients: A matched control study. Obstet Gynecol (New York 1953)2001; 97(4): 555–560.
7.
AyhanA.TaskiranCSimsekS, et al.Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?Int J Gynecol Cancer2006; 16(2): 805–808.
8.
CreasmanW.T.HendersonDHinshawW, et al.Estrogen Replacement Therapy in the Patient Treated for Endometrial Cancer. Obstetrics Gynecol (New York 1953)1986; 67(3): 326–330.
9.
LeeRBBurkeTWParkRC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol1990; 36(2): 189–191.
10.
ChapmanJADiSaiaPJOsannK, et al.Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol1996; 175(5): 1195–1200.
11.
PoulsenHKJacobsenMBertelsenK, et al.Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low risk cases. Int J Gynecol Cancer1996; 6: 38–43.
12.
BasakciAKirkaliZTuzelE, et al.Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder. Eur Urol2002; 41(3): 342–345.
13.
DeliTOroszMJakabA. Hormone replacement therapy in cancer survivors – Review of the literature. Pathol Oncol Res2020; 26: 63–78.
14.
UhligAHosseiniASASimonJ, et al.Gender specific differences in disease-free, cancer specific and overall survival after radical cystectomy for bladder cancer: A systematic review and meta-analysis. J Urol2018; 200: 48–60.
15.
ModiMDhilloW. Neurokinin 3 receptor antagonism: A novel treatment for menopausal hot flushes. Neuroendocrinol2019; 109(3): 242–248.
